« Previous
Next »
The American Journal of Surgery
Volume 196, Issue 4
, Pages 500-504
, October 2008
Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients
References
- Hospital variables associated with quality of care for breast cancer patients. JAMA. 1991;266:3429–3432
- Survival disadvantage among MedicAid-insured breast cancer patients treated with breast conserving surgery without radiation therapy. Breast Cancer Res Treat. 2007;101:207–214
- Radiation therapy omission after breast-conserving surgery is associated with reduced breast-specific survival in elderly women with breast cancer. Am J Surg. 2006;191:749–755
- . Breast conserving surgery with or without radiotherapy: Pooled analysis for risks of ipsilateral breast breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96:15–21
- Omission of radiotherapy after breast conserving surgery: survival impact and time trends. Radiother Oncol. 2003;671:147–158
- Outcomes of breast cancer in patients who use alternative therapies as primary treatment. Am J Surg. 2006;192:471–473
- . When not to give radiation therapy after breast conservation surgery for breast cancer. J Surg Oncol. 2000;74:273–277
- Audit of compliance to adjuvant chemotherapy and radiotherapy guidelines in breast cancer in a cancer network. Breast. 2003;12:136–141
- . A breast cancer review of compliance with National Comprehensive Cancer Network breast cancer guidelines. Am J Surg. 2006;192:525–527
- Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357–1362
- . The consequence of undertreating breast cancer in the elderly. J Am Coll Surg. 2001;192:698–707
- Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006;24:4377–4383
- . Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003;21:602–606
- . Patients' understanding of and compliance with medications: the sixth vital sign. Mayo Clin Proc. 2005;80:983–987
- . Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet. 1998;351:1451–1467
PII: S0002-9610(08)00525-4
doi: 10.1016/j.amjsurg.2008.06.027
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Surgery
Volume 196, Issue 4
, Pages 500-504
, October 2008
